P. Baas et al., PHOTODYNAMIC THERAPY AS ADJUVANT THERAPY IN SURGICALLY TREATED PLEURAL MALIGNANCIES, British Journal of Cancer, 76(6), 1997, pp. 819-826
Five patients with a pleural malignancy (four malignant mesotheliomas
and one localized low grade carcinoid) were treated with maximal surgi
cal resection of the tumour followed by intraoperative adjuvant photod
ynamic therapy (PDT). The additional photodynamic treatment was perfor
med with light of 652 nm from a high power diode laser, and meta-tetra
hydroxy phenylchlorin as the photosensitizer. The light delivery to th
e thoracic cavity was monitored by in situ isotropic light detectors.
The position of the light delivery fibre was adjusted to achieve optim
al light distribution, taking account of reflected and scattered light
in this hollow cavity. There was no 30-day post-operative mortality a
nd only one patient suffered from a major complication (diaphragmatic
rupture and haematopericardium). The operation time was increased by a
maximum of 1 h to illuminate the total hemithoracic surface with 10 J
cm(-2) (incident and scattered light). The effect of the adjuvant PDT
was monitored by examination of biopsies taken 24 h after surgery und
er thoracoscopic guidance. Significant damage, including necrosis, was
observed in the marker lesions with remaining malignancy compared wit
h normal tissue samples, which showed only an infiltration with PMN ce
lls and oedema of the striated muscles cells. Of the five patients tre
ated, four are alive with no signs of recurrent tumour with a follow-u
p of 9-11 months. One patient was diagnosed as having a tumour dissemi
nation in the skin around the thoracoscopy scar and died of abdominal
tumour spread. Light delivery to large surfaces for adjuvant PDT is fe
asible in a relatively short period of time (<1 h). In situ dosimetry
ensures optimal light distribution and allows total doses (incident pl
us scattered light) to be monitored at different positions within the
cavity. This combination of light delivery and dosimetry is well suite
d for adjuvant treatment with PDT in malignant pleural tumours.